Clinical Trials on Papillomavirus Infections

Total 56569 results

University of Washington

Completed

Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM) (WHIM)

Papillomavirus Infections

United States
Takeda

Terminated

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Papillomavirus Infections

United States, Canada
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Recruiting

Multilevel HPV Self-Testing Intervention for the Increase of Cervical Cancer Screening Among Women in Appalachia

Cervical Carcinoma | Human Papillomavirus Infection

United States
Lund University
Swedish Cancer Society

Completed

Use of Human Papillomavirus Persistence for Determination of Treatment Efficacy Among Women With Cervical Dysplasia

Cervical Intraepithelial Neoplasia | Human Papillomavirus Infection

Sweden
GlaxoSmithKline

Completed

Human Papillomavirus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Biologicals Novel HPV Vaccine

Infections, Papillomavirus | Papillomavirus Vaccines

Belgium, United States
GlaxoSmithKline

Completed

Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.

Infections, Papillomavirus | Papillomavirus Vaccines

Denmark, Poland, Lithuania
Assiut University

Completed

Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Human Papillomavirus Infection

Egypt
Duke University
Centers for Disease Control and Prevention

Completed

Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting

Pertussis | Influenza Vaccine | Papillomavirus Infection

United States
Takeda

Terminated

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Papillomavirus Infections

United States, Canada, Puerto Rico
Serum Institute of India Pvt. Ltd.
Bill and Melinda Gates Foundation

Not yet recruiting

Clinical Study to Evaluate SIIPL qHPV Vaccine (CERVAVAC®) in Women Living With HIV Aged 15-25 Years

Human Papillomavirus Infection

Kenya, Mozambique, South Africa
National Cancer Institute (NCI)

Active, not recruiting

Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial (PRISMA)

Cervical Carcinoma | Human Papillomavirus Infection

Costa Rica
The Alfred
Merck Sharp & Dohme LLC

Completed

Human Papillomavirus (HPV) Infection in Young Men Who Have Sex With Men (HYPER)

Human Papillomavirus

Australia
University of Florida
Merck Sharp & Dohme LLC

Completed

Prevalence, Persistence, and Risk Factors for Oral Human Papillomavirus (HPV) Infections in College Women (HOP-IN)

Human Papillomavirus

United States
Jhpiego
Botswana Ministry of Health

Completed

Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Botswana

Cervical Cancer | Human Papillomavirus Infection

Botswana
University of Cincinnati

Recruiting

Let's K-Talk - HPV Study for Ethnic Koreans

Papillomavirus Vaccines | Human Papillomavirus Viruses

United States
Lee's Pharmaceutical Limited

Unknown

Yallaferon in Chinese Population

HPV Infection

China
University Hospital, Tours

Completed

Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention (APACHE-2)

Cervical Cancer | Human Papillomavirus Infection
Merck Sharp & Dohme LLC

Completed

GARDASIL Reexamination Study (V501-059)

Human Papillomavirus (HPV) Infection
Shandong University
Qilu Hospital of Shandong University

Recruiting

Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female

High Risk Human Papillomavirus Infection | Low Grade Squamous Intraepithelial Lesion

China
AGUNCO Obstetrics and Gynecology Centre

Completed

Polyhexamethylene Biguanide Increases the Regression Rate of Human Papillomavirus (HPV) Infection

HPV Infection

Italy
GlaxoSmithKline

Completed

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Human Papillomavirus (HPV) Infection

Senegal, Tanzania
Imperial College London
Public Health England

Recruiting

Screening for HPV and Cervical Cancer in Young Women With Perinatally Acquired HIV (SHiP)

HIV Infections | Cervical Cancer | Human Papillomavirus Infection

United Kingdom
ANRS, Emerging Infectious Diseases

Not yet recruiting

HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population (PrevHPV-TG)

Sexually Transmitted Diseases | Human Papillomavirus Infection | Human Immunodeficiency Virus Infection
Merck Sharp & Dohme LLC

Completed

GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)

Papillomavirus Infections
University of British Columbia
Uganda Cancer Institute

Completed

Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge) (ASPIRE)

Cervical Cancer | Papillomavirus Infections | Pre-Cancerous Dysplasia | Human Papillomavirus 16 | Human Papillomavirus 18

Uganda
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 3 (HYPER3)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
GlaxoSmithKline

Completed

Efficacy Study of HPV-16/18 Vaccine (GSK 580299) to Prevent HPV-16 and/or -18 Cervical Infection in Young Healthy Women

Infections, Papillomavirus
Laval University

Unknown

HPV Prevalence in 16-20 Year Old Males

HPV Infection

Canada
Hospices Civils de Lyon

Completed

HPV Vaccination in Women With Cystic Fibrosis (VACCIN-HPV-MUC)

Human Papillomavirus Infection

France
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Papillomavirus Infections

United States, Belgium, Brazil, Colombia, Czechia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Spain, Taiwan, Thailand
ANRS, Emerging Infectious Diseases
University Hospital, Bordeaux; Saint-Louis Hospital, Paris, France; Bichat Hospital and other collaborators

Recruiting

Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo. (DepIST-H)

HIV Infections | Papillomavirus Infections

Togo
National Taiwan University Hospital
National Science Council, Taiwan; National Health Research Institutes, Taiwan

Unknown

Clinicopathological and Molecular Correlation of Acrochordon in Relation to Human Papillomavirus Infection

HPV | Human Papillomavirus | Acrochordon | Skin Tag | Soft Fibroma

Taiwan
Monash University
The Alfred; University of Melbourne

Recruiting

Human Papillomavirus in Young People Epidemiological Research 4 (HYPER4)

Cancer | Anal Cancer | HPV Infection | HPV | Human Papillomavirus Infection | Men | HPV 16 Infection

Australia
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
Ulla Bonde van Zwol
University of Southern Denmark; Region of Southern Denmark; MCM Vaccines B.V.

Unknown

Human Papillomavirus and Pregnancy (HPVandPregn)

HPV-infection in Pregnant Women

Denmark
Shanghai Zerun Biotechnology Co.,Ltd
Yuxi Zerun Biotechnology Co., Ltd.

Completed

Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

HPV Infection

China
Merck Sharp & Dohme LLC

Completed

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

HPV Infections
Merck Sharp & Dohme LLC

Completed

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

HPV Infections
University Hospital, Ghent

Completed

Study of the Molecular Mechanisms Underlying the Cross-neutralizing Capacity of AS04-adjuvanted HPV Vaccine (Cervarix®) in Comparison With the Aluminiumhydroxyphosphate Sulphate Adjuvanted HPV Vaccine (Gardasil®) (HPVXneutra001)

Infection With Human Papillomavirus

Belgium
Fundació Institut de Recerca de l'Hospital de la...

Unknown

Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CIN

Disease Progression | Papillomavirus Infections | High-Grade Squamous Intraepithelial Lesions | Neoplasm Regression, Spontaneous

Spain
GlaxoSmithKline

Completed

Follow-up Study of GSK Biologicals' Human Papilloma Virus (HPV) Vaccine to Prevent Cervical Infection in Young Adults

Infections, Papillomavirus

Canada, United States, Brazil
GlaxoSmithKline

Terminated

Study of Natural History of Human Papillomavirus (HPV) Infections in Adult Women With Recurrent Conizations in Norway

Infections, Papillomavirus

Norway
Merck Sharp & Dohme LLC

Completed

V501 Efficacy Study in Women Aged 18 to 26 (V501-027)

HPV Infections
University of Alabama at Birmingham

Completed

A Study to Identify Markers in Blood and Tissue of HPV Clearance

HPV Infections

United States
Merck Sharp & Dohme LLC

Suspended

Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034)

HPV Infections
M.D. Anderson Cancer Center

Completed

Sexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection

Head and Neck Cancer | Oropharyngeal Cancer | Human Papillomavirus Infection

United States
Shanghai Bovax Biotechnology Co., Ltd.

Completed

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

HPV Infections

China
Merck Sharp & Dohme LLC

Completed

V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)

HPV Infections
University of Washington

Active, not recruiting

Immunogenicity of Fractional Dose of the HPV Vaccines

HPV Infection | HPV Vaccine

United States
Procare Health Iberia S.L.

Completed

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV (PAPILOCAN)

HPV Infection | Lesion Cervix

Spain

Clinical Trials on Papillomavirus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations